Entrepreneur back in game with medical software

In a Detroit Crain's article on July 22, 2018, 12:18 AM, Tom Henderson reported that Jennifer Baird has a new venture in Fifth Eye Inc., which is a spinoff from the University of Michigan. Many remember JenniferĀ from the sale of Accuri Cytometers to Becton, Dickinson & Co. for $205 million back in 2011. In 2005, she presented at a NEF forum meeting. "Fifth Eye is developing software to warn medical professionals that certain patients who seem to be doing well after an operation are actually, based on almost imperceptible changes in their vital signs, at risk for serious deterioration in their conditions." Read MoreĀ